Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings.

Pīrāgs V, El Damassy H, Dąbrowski M, Gönen MS, Račická E, Martinka E, Giaconia J, Stefanski A; B001 Study Investigators.

Int J Clin Pract. 2012 Nov;66(11):1033-41. doi: 10.1111/j.1742-1241.2012.03001.x. Erratum in: Int J Clin Pract. 2013 Jun;67(6):e1.

PMID:
23067027
[PubMed - indexed for MEDLINE]
2.

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, Rosenstock J, Endahl LA, Francisco AM, Hollander P; NN1250-3582 (BEGIN BB T2D) Trial Investigators.

Lancet. 2012 Apr 21;379(9825):1498-507. doi: 10.1016/S0140-6736(12)60205-0.

PMID:
22521072
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.

Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M, Wolka AM, Boardman MK; DURATION-4 Study Group.

Diabetes Care. 2012 Feb;35(2):252-8. doi: 10.2337/dc11-1107. Epub 2011 Dec 30.

PMID:
22210563
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators.

Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29.

PMID:
22038523
[PubMed - indexed for MEDLINE]
5.

[Can serologic markers be indicators of dietary errors in patients with celiac disease?].

Ilavská A, Beno I, Gomolcák P, Paulovicová E.

Vnitr Lek. 2004 Mar;50(3):208-12. Slovak.

PMID:
15125371
[PubMed - indexed for MEDLINE]
6.

[Importance of determining serologic markers in patients with celiac disease].

Ilavská A, Paulovicová E, Mikulecký M.

Cas Lek Cesk. 2002 Aug 2;141(15):487-90. Slovak.

PMID:
12226916
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk